It is thought that viral Covid-19 infection, which has respiratory symptoms such as fever, cough, and shortness of breath, may also have an ocular presentation.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Covid-19 infection, which appeared first in the Wuhan region of China in 2019 and identified as the new type of coronavirus, has spread rapidly to different countries and was declared as a pandemia by the World Health Organization.
📊
Key Findings & Data:Covid-19 infection, which appeared first in the Wuhan region of China in 2019 and identified as the new type of coronavirus, has spread rapidly to different countries and was declared as a pandemia by the World Health Organization.
💡
Conclusion & Impact:It is thought that viral Covid-19 infection, which has respiratory symptoms such as fever, cough, and shortness of breath, may also have an ocular presentation.
Covid-19 infection, which appeared first in the Wuhan region of China in 2019 and identified as the new type of coronavirus, has spread rapidly to different countries and was declared as a pandemia by the World Health Organization. It is thought that viral Covid-19 infection, which has respiratory symptoms such as fever, cough, and shortness of breath, may also have an ocular presentation.
Özet
2019 yılında Çin’in Wuhan bölgesinde ortaya çıkan ve yeni tip koronavirus olarak tanımlanan Covid-19 enfeksiyonu, hızla farklı ülkelere yayılmış ve Dünya Sağlık Örgütü tarafından pandemi ilan edilmiştir. Ateş, öksürük, nefes darlığı gibi solunumsal semptomlar gösteren viral Covid-19 enfeksiyonunun oküler prezentasyonu olabileceği akla gelmektedir. Pandemi boyunca acil servisimize konjonktivit semptomları ile başvuran hastalarda Covid-19 hikayesi veya semptomlarının olması dikkatimizi çekmiştir.
Ademoğlu, E., İslam, M. M., Aksel, G., Eroğlu, S. E. (2020). A Rare Presentation of Covid-19: Case Series with Conjunctivitis and Ocular Involvement. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 22 Sayı: 3, 483–487. https://doi.org/10.24938/kutfd.789772
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine 2020;382(18):1708-20.
Lu R, Zhao X, Li J, Niu P, Yang, Wu H et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74.
Loffredo L, Pacella F, Pacella E, Tiscione G, Oliva A, Violi, F. Conjunctivitis and COVID‐19: a meta‐analysis. Journal of Medical Virology. 2020;92(9):1413-4.
Lu C, Liu X, & Jia Z. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet (London, England). 2020;395(10224):e39.
Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocular Immunology and Inflammation. 2020;28(3):391-95.
Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmology. 2020;138(5):575-8.
Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19): A case report. Canadian Journal of Ophthalmology. 2020;55(4):125-129.
Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection. Journal of Medical Virology. 2020; 92(6):589-94.